Stamford, Connecticut, United States In 1892 was created Purdue Pharma, which is appeared as Corporate Investor. The leading representative office of defined Corporate Investor is situated in the Stamford. The venture was found in North America in United States.
The higher amount of exits for fund were in 2016. The important activity for fund was in 2008. The fund is constantly included in less than 2 deals per year. The real fund results show that this Corporate Investor is 20 percentage points more often commits exit comparing to other companies. Comparing to the other companies, this Purdue Pharma performs on 11 percentage points more the average number of lead investments. The common things for fund are deals in the range of 10 - 50 millions dollars.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Purdue Pharma, startups are often financed by Tichenor Ventures, HBM Healthcare Investments AG, Auven Therapeutics. The meaningful sponsors for the fund in investment in the same round are OUP (Osage University Partners), HBM Healthcare Investments AG, Tichenor Ventures. In the next rounds fund is usually obtained by Tichenor Ventures, HBM Healthcare Investments AG, Auven Therapeutics.
Among the various public portfolio startups of the fund, we may underline Kolltan Pharmaceuticals For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular fund investment industries, there are Pharmaceutical, Biotechnology. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund.
This organization was formed by George Frederick Bingham, John Purdue Gray.
Related Funds
| Fund Name | Location |
| Acer | New Taipei, Taiwan |
| Amigo Health | Grapeview, United States, Washington |
| AsiaInfo-Linkage | Beijing, Beijing, China |
| Banque Populaire Rives de Paris | France, Ile-de-France, Paris |
| Beijing Yingpuruida Touzi | Beijing, Beijing, China |
| China Minsheng Investment Group | China, Shanghai |
| EvoBus | Bayern, Germany, Neu-ulm |
| Graystone Venture Funds | - |
| Grey | New York, New York, United States |
| Launchpad Capital | California, Oakland, United States |
| Margie and Robert E. Petersen Foundation | California, Pasadena, United States |
| Neon Capital Partners Ltd. | Leicestershire, Normanton, United Kingdom |
| Novotech Investments | Newcastle upon Tyne, North East, United Kingdom |
| Okamura | Japan, Kanagawa Prefecture, Yokohama |
| Paysmark Verwaltungs- und Beteiligungsgesellschaft mbH | - |
| Spinel Capital | China, Shanghai |
| Vestia | Fort Wayne, Indiana, United States |
| Xiaodu TV | - |
| Yazam | New York, New York, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Kolltan Pharmaceuticals | $5M | 12 Oct 2009 | New Haven, Connecticut, United States | ||
Kolltan Pharmaceuticals | $40M | 31 Jul 2008 | New Haven, Connecticut, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Kolltan Pharmaceuticals | $5M | 12 Oct 2009 | New Haven, Connecticut, United States | ||
Kolltan Pharmaceuticals | $40M | 31 Jul 2008 | New Haven, Connecticut, United States |
